Mark L. Baum, Chief Executive Officer at Imprimis Pharmaceuticals, Inc. (IMMY), bought 356,000 shares at $1.79 ($623K) on 2016-12-19, disclosed to the SEC on 2016-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.72 | 200,000 | $344K | 55.2% |
| 2 | $1.79 | 156,000 | $279K | 44.8% |
| Total | $1.75 avg | 356,000 | $623K | 100% |
| Filing → |
| HROW | BUY | 2023-11-16 | $122K | — | Filing → |
| HROW | BUY | 2023-08-15 | $99K | — | Filing → |
| HROW | BUY | 2022-12-23 | $335K | — | Filing → |